Home » Topics » BioWorld

BioWorld
RSS

BDNF: A POTENTIAL PARKINSON'S THERAPEUTIC

March 21, 1991

NEWPORT SETTLES FOR $1.88M PLUS INTEREST

March 21, 1991

HYCOR TO GET VENTREX AND ITS TAX CREDITS

March 21, 1991

NIH PANEL AGREES BST MILK IS SAFE

March 20, 1991

EARNINGS REPORTS

March 20, 1991

NEWS BRIEFS

March 20, 1991

CETUS DISCUSSES SETTLEMENT WITH DU PONT

March 20, 1991

GI CREATES SHELL, FILES TWO OFFERINGS

March 20, 1991

CEPHALON FILES IPO TO FUND PRODUCT TRIALS

March 20, 1991

U.K. APPROVES AMGEN'S NEUPOGEN

March 19, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...